Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both FrontView REIT, Inc. (FVR) and Sabra Healthcare (SBRA). But which of these two stocks is more attractive to value investors?
Sabra Health Care REIT is rated a buy, reflecting portfolio growth, reasonable valuation, and robust geographic diversification. SBRA demonstrates strong revenue and NOI growth but faces declining EBITDA margins and flat long-term dividend growth, tempering its income appeal. The REIT maintains an investment-grade balance sheet, modest debt-to-equity, low operator concentration, and adequate AFFO dividend coverage with a 5.6% yield.
Sabra Health Care REIT is a 'Buy' with a near 6% yield and 13x forward P/FFO, supported by favorable demographics and industry supply constraints. SBRA's Q1 2026 normalized FFO grew 9% YoY, driven by 14.4% same-store SHOP NOI growth and robust occupancy gains. Management is aggressively deploying capital into SHOP-focused acquisitions at 8% initial cash yields, with a strong pipeline and mostly fixed operating expenses enabling positive operating leverage.
Global X SuperDividend REIT ETF (NYSEARCA:SRET) holds roughly 30 of the highest-yielding REITs worldwide, equally weighted, with monthly distributions.
U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.
Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.39 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to FFO of $0.37 per share a year ago.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2026. FIRST QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2026 were as follows: Net Income: $0.16 FFO: $0.37 Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.39 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.46x Senior Housing - Leased: 1.58x Behavi.
Advisors Capital Management LLC raised its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 3.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,382,935 shares of the real estate investment trust's stock after purchasing an additional 73,281 shares during
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Wells Fargo's 29th Annual Real Estate Securities Conference on May 4 – May 6, 2026, at The Charleston Place in Charleston, South Carolina. About Sab.
